Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/paks-rac-cdc42-p21-activated-kinases/maruta/descriptif_3574389
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3574389

PAKs, RAC/CDC42 (p21)-activated Kinases Towards the Cure of Cancer and Other PAK-dependent Diseases

Langue : Anglais

Coordonnateur : Maruta Hiroshi

Couverture de l’ouvrage PAKs, RAC/CDC42 (p21)-activated Kinases
This book covers a variety of cutting-edge basic and clinical PAK research ranging from laboratory benches to hospital beds. The goal of this book is to inspire not only biomedical research scientists and university students, but also a variety of patients who suffer from PAK-dependent diseases and clinical doctors who try to cure or delay these PAK-dependent diseases.

This book consists of 9 chapters which deal with different aspects of this kinase. These chapters are written by more than two dozen world-leading PAK experts. Each of these will provide updated biomedical information as well as future insight to a wide range of readers who are interested in this unique kinase and both its pathological and physiological roles as well as its functional evolution from its ancestral origins.



  • This publication will be the very first book ever published solely focused on PAK family kinases.
  • Each chapter deals with the latest progress in PAK research written by a leading PAK expert with his or her own ideas and insight.  
  • Each chapter of this book has been written in such a way that clinical doctors who seek the effective cure of these formidable diseases, in addition to research scientists and biomedical students will value this book.
  • This book describes in detail a number of PAK blockers which would be potentially useful for the therapy of these PAK-dependent diseases, and some of them are indeed available on the market inexpensively, without any side effect.

Chapter 1: Functional Maturation of PAKs Chapter 2: Oncogenicity of PAKs and Their Substrates Chapter 3:Natural or Synthetic Therapeutics that Block PAKs Chapter 4:PAK1 in Parasites-Host Interaction Chapter 5: PAK1 in Brain Diseases Chapter 6: PAK1 in Alzheimer’s and Huntington’s diseases Chapter 7: PAK1 Controls the Lifespan Chapter 8: PAK 4-6 in Cancer and Neuronal Development

This book will be of interest to pharmaceutical scientists and other biomedical research scientists, clinical doctors and even patients who suffer from PAK-dependent diseases.

Date de parution :

Ouvrage de 276 p.

15.2x22.9 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

85,95 €

Ajouter au panier

Thème de PAKs, RAC/CDC42 (p21)-activated Kinases :

En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.
FERMER